Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma.
暂无分享，去创建一个
S. Jagannath | S. Lonial | T. Zimmerman | N. Munshi | A. Chanan-Khan | J. Rosenblatt | S. Ailawadhi | F. Rharbaoui | L. Heffner | A. Wartenberg-Demand | K. Anderson | Thomas Q. Haeder | Markus Ruehle